Heico Stock Extends A 7-Day Losing Streak To An 8.4% Loss
A seven-day slide in the company’s stock prompts a fresh look at the tension between its strong business metrics and its high valuation.
Heico (HEI) stock has now moved lower for 7 consecutive trading days, resulting in a cumulative loss of 8.4%. That streak has erased about $4.2 billion from the company’s market value.
This recent decline has abruptly reversed what was otherwise a resilient quarter. While the stock’s trailing one-month return has slipped to -9.8%, its trailing three-month return stands at just -2.1%. Over the past twelve months, the stock has returned +4.3%.
HEI Versus The S&P 500, Streak And Beyond
- Karman Stock: 12 Straight Red Days, Down 34%
- How Will Guidewire Software Stock React To Its Upcoming Earnings?
- How Will Samsara Stock React To Its Upcoming Earnings?
- How Will Zscaler Stock React To Its Upcoming Earnings?
- 9 Red Days In A Row: BridgeBio Pharma Stock Is Down 8.8%
- Dycom Industries Stock: 11 Straight Red Days, Down 34%
Here is how HEI stock stacks up against the S&P 500 over the streak and the periods around it:
| Return Period | HEI | S&P 500 |
|---|---|---|
| 1D | -1.8% | -0.7% |
| 7D (Current Streak) | -8.4% | -0.6% |
| 1M (21D) | -9.8% | 0.4% |
| 3M (63D) | -2.1% | 0.3% |
| YTD 2026 | 0.6% | 11.5% |
| 2025 | 36.2% | 16.4% |
| 2024 | 33.1% | 23.3% |
| 2023 | 16.6% | 24.2% |
What does the data show about this price?
The slide appears specific to the company, not the broader market. Over the same 7 trading days the S&P 500 returned -0.6%. The market seems to be weighing a business with strong performance against a high valuation. Revenue over the last twelve months grew 20.7%, well above the S&P 500 median of 8.3%. Its operating margin of 24.0% also exceeds the index median of 18.5%.
At the same time, HEI trades at a price-to-earnings multiple of 53.6. This is significantly higher than the S&P 500 median of 23.2 and the median of 27.8 for S&P 500 Industrials stocks.
How should an investor treat a streak?
A streak is information, not an instruction. It signals that a stock has sustained momentum and captured market attention, but it doesn’t tell you whether the new price is fair. The disciplined move is to use the streak as a reason to check the business against that price.
The numbers here provide a starting point for that check: a company with above-average growth and margins is now available at a lower price, though its valuation multiple remains high relative to the market.
If the drop has you weighing an entry, resist buying a falling price alone. Our Buy the Dip screen ranks the marked-down names where growth and cash generation still support a recovery.
Those watching the group rather than this one name have another route: an aerospace & defense ETF like MISL holds the sector rather than this one name. It is still a concentrated bet on that one theme, though, which is exactly the gap the portfolio below closes.
Weakness In One Name Should Be Noise, Not News
For a diversified holder, a streak like this is a data point. For a concentrated one, it is a hole in the plan. The difference is never the stock; it is the portfolio built around it.
Building that portfolio is what the Trefis High Quality (HQ) Portfolio does: roughly 30 businesses with the cash generation and balance-sheet strength to absorb a bad month, selected and rebalanced by rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Make the next streak, in either direction, someone else’s drama.